I have heard of these drug companies all my life, but it wasn't until Mounjaro that I have taken a keen interest in the biotech world. Most of that is because of my own health interest, some is just general curiosity, but a lot of it is because I now invest in Eli Lilly.
One thing I've learned - promising drugs have a long hurdle to get to the public, and many wind up on the trash heap.
Here are some of the drugs that had tough trials in '22.
https://www.fiercebiotech.com/special-reports/2022s-top-10-clinical-trial-flops